Fig. 2From: Clinical significance of serum anti-granulocyte–macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitisGMAb levels in serum. GMAb levels in serum of aPAP (n = 110), sarcoidosis (n = 90), HP (n = 44), healthy controls (n = 31), sarcoidosis with complication of aPAP (n = 2) and HP with complication of aPAP (n = 1) patients. Horizontal dotted line shows the 95th percentile value for healthy controls (1.42 μg/mL) and horizontal solid line shows cut-off value (3.33 μg/mL) for discriminating aPAP from healthy controls. GMAb anti-granulocyte–macrophage colony-stimulating factor autoantibody, aPAP autoimmune pulmonary alveolar proteinosis, HP hypersensitivity pneumonitisBack to article page